Clinical Trials Browser

OTHER × Head and Neck Neoplasms × Panitumumab × Clear all

NCT03733210 2023-05-19

Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck Cancer

Phase 1 Completed

14 enrolled 12 charts

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT01264328 2019-04-16

VECTITAX

Phase 2 Completed

Head and Neck Neoplasms

NCT00798655 2017-10-03

Trial of Postoperative Radiation, Cisplatin, and Panitumumab in Locally Advanced Head and Neck Cancer

Phase 2 Completed

46 enrolled 6 charts

Head and Neck Neoplasms

NCT01312493 2015-08-28

Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab

Phase 2 Withdrawn

Head and Neck Neoplasms